BioVie Inc.
BIVI
$1.97
-$0.10-4.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.51M | 8.76M | 8.19M | 8.79M | 8.57M |
| Depreciation & Amortization | 178.20K | 229.20K | 229.20K | 229.20K | 229.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.65M | 20.60M | 18.20M | 19.23M | 18.07M |
| Operating Income | -22.65M | -20.60M | -18.20M | -19.23M | -18.07M |
| Income Before Tax | -22.07M | -19.92M | -17.43M | -18.48M | -17.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.07 | -19.92 | -17.43 | -18.48 | -17.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.07M | -19.92M | -17.43M | -18.48M | -17.54M |
| EBIT | -22.65M | -20.60M | -18.20M | -19.23M | -18.07M |
| EBITDA | -22.47M | -20.37M | -17.97M | -19.00M | -17.84M |
| EPS Basic | -3.16 | -4.33 | -5.13 | -8.92 | -14.94 |
| Normalized Basic EPS | -1.97 | -2.70 | -3.20 | -5.55 | -9.00 |
| EPS Diluted | -3.17 | -4.33 | -5.14 | -8.93 | -14.94 |
| Normalized Diluted EPS | -1.97 | -2.70 | -3.20 | -5.55 | -9.00 |
| Average Basic Shares Outstanding | 28.60M | 22.54M | 16.84M | 10.50M | 5.92M |
| Average Diluted Shares Outstanding | 28.60M | 22.54M | 16.84M | 10.50M | 5.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |